15788-14-4

Upstream product

• 15896-61-4 2-(4-amino-3-nitrophenyl)ethanol 

Downstream Products

• 913652-84-3 2-(2-(2-({5-chloro-2-[(2-methylpropyl)oxy]phenyl}methyl)-1,3-oxazol-4-yl)-3H-benzimidazol-5-yl)ethanol 
• 913652-93-4 2-(2-(2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazol-4-yl)-3H-benzimidazol-5-yl)ethanol 
• 913653-27-7 (2-{2-[2-({5-chloro-2-[(2-methylpropyl)oxy]phenyl}methyl)-1,3-oxazol-4-yl]-3H-benzimidazol-5-yl}ethyl)dimethylamine hydrochloride 

Relevant academic research and scientific papers

OXAZOLE AND THIAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PGE2 MEDIATED DISORDERS

Compounds of formula (I) or a pharmaceutiically acceptable derivative thereof: wherein X, Z, Y', Y'', R1 ,R2a, R2b, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS

Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: (I) wherein X, Z, R1 ,R2a, R2b, R3, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.